Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tefinostat in hepatocellular carcinoma
NCT02759601Phase 2Unknown
- Sponsor
- Queen Mary University of London
- Start
- Jan 2013
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tefinostat in hepatocellular carcinoma (HCC), sponsored by Queen Mary University of London. Status: unknown.
02
Drugs
tefinostat
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT02759601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02759601.